All Studies

Inhibition of GluN2B pathway is involved in the neuroprotective effect of silibinin on streptozotocin-induced Alzheimer's disease models.

The study looked at the effects of Silibinin, a natural compound, on N-methyl-D-aspartate receptors (NMDARs) in Alzheimer's disease. The experimenters found that Silibinin has neuroprotective effects on Alzheimer's disease models. The study suggests that Silibinin has potential as a treatment for Alzheimer's disease, and further research is needed.

Liu P et al (2023).
Phytomedicine.
PubMed:
36610115